Top compounds associated with response to TENM3


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.0092 0.8
mRNA BRD-K30019337 CTRPv2 pan-cancer AAC -0.019 0.8
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.0082 0.8
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.0088 0.8
mRNA AZD0530 FIMM pan-cancer AAC -0.041 0.8
mRNA Sunitinib CTRPv2 pan-cancer AAC -0.0087 0.8
mRNA tandutinib CTRPv2 pan-cancer AAC 0.0091 0.8
mRNA Methotrexate CTRPv2 pan-cancer AAC -0.0089 0.8
mRNA lapatinib UHNBreast pan-cancer AAC 0.071 0.8
mRNA CIL55A CTRPv2 pan-cancer AAC -0.012 0.8
Download CSV